Porsche Forecast, price target & analysts
Porsche Target price 2025 - Analyst rating & recommendation
Porsche Classifications & Recommendation:
Porsche Price Target
| Target Price | €45.90 |
| Price | €45.52 |
| Potential | 0.83% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Porsche 2026 . The average Porsche target price is €45.90. This is 0.83% higher than the current stock price. The highest price target is €73.50 61.47% , the lowest is €37.37 17.90% . | |
| A rating was issued by 30 analysts: 5 Analysts recommend Porsche to buy, 13 to hold and 12 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Porsche stock has an average upside potential 2026 of 0.83% . Most analysts recommend the Porsche stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2032
26 Analysts have issued a sales forecast Porsche 2025 . The average Porsche sales estimate is €38.0b . This is 22.37% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €39.9b 18.52% , the lowest is €34.8b 28.87% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | €40.1b | 1.10% |
|---|---|---|
| 2025 | €38.0b | 5.21% |
| 2026 | €39.0b | 2.59% |
| 2027 | €40.6b | 4.14% |
| 2028 | €44.3b | 9.06% |
| 2029 | €48.2b | 8.88% |
| 2030 | €50.0b | 3.79% |
| 2031 | €51.7b | 3.38% |
| 2032 | €54.2b | 4.71% |
22 Analysts have issued an Porsche EBITDA forecast 2025. The average Porsche EBITDA estimate is €6.8b . This is 35.97% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €9.4b 11.55% , the lowest is €4.8b 54.63% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | €10.0b | 9.28% |
|---|---|---|
| 2025 | €6.8b | 32.04% |
| 2026 | €8.0b | 17.40% |
| 2027 | €9.1b | 14.31% |
| 2028 | €10.3b | 13.10% |
| 2029 | €11.6b | 12.54% |
| 2030 | €12.1b | 4.14% |
| 2031 | €13.4b | 11.03% |
| 2032 | €14.0b | 4.48% |
EBITDA Margin
| 2024 | 24.89% | 8.26% |
|---|---|---|
| 2025 | 17.84% | 28.33% |
| 2026 | 20.42% | 14.46% |
| 2027 | 22.42% | 9.79% |
| 2028 | 23.25% | 3.70% |
| 2029 | 24.03% | 3.35% |
| 2030 | 24.11% | 0.33% |
| 2031 | 25.89% | 7.38% |
| 2032 | 25.84% | 0.19% |
26 Porsche Analysts have issued a net profit forecast 2025. The average Porsche net profit estimate is €1.5b . This is 62.28% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.0b 52.28% , the lowest is €1.0b 75.45% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | €3.6b | 30.35% |
|---|---|---|
| 2025 | €1.5b | 56.85% |
| 2026 | €2.5b | 58.58% |
| 2027 | €3.1b | 25.51% |
| 2028 | €4.0b | 29.62% |
| 2029 | €4.8b | 20.97% |
| 2030 | €5.2b | 6.51% |
| 2031 | €5.2b | 1.06% |
| 2032 | €5.4b | 2.79% |
Net Margin
| 2024 | 8.96% | 29.57% |
|---|---|---|
| 2025 | 4.08% | 54.47% |
| 2026 | 6.31% | 54.66% |
| 2027 | 7.60% | 20.44% |
| 2028 | 9.03% | 18.82% |
| 2029 | 10.03% | 11.07% |
| 2030 | 10.30% | 2.69% |
| 2031 | 10.07% | 2.23% |
| 2032 | 9.88% | 1.89% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
26 Analysts have issued a Porsche forecast for earnings per share. The average Porsche EPS is €1.70 . This is 62.31% lower than earnings per share in the financial year 2024. The highest EPS forecast is €2.15 52.33% , the lowest is €1.11 75.39% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | €3.94 | 30.39% |
|---|---|---|
| 2025 | €1.70 | 56.85% |
| 2026 | €2.70 | 58.82% |
| 2027 | €3.39 | 25.56% |
| 2028 | €4.39 | 29.50% |
| 2029 | €5.31 | 20.96% |
| 2030 | €5.65 | 6.40% |
| 2031 | €5.71 | 1.06% |
| 2032 | €5.87 | 2.80% |
P/E ratio
| Current | 10.06 | 28.28% |
|---|---|---|
| 2025 | 26.66 | 165.13% |
| 2026 | 16.81 | 36.95% |
| 2027 | 13.39 | 20.35% |
| 2028 | 10.33 | 22.85% |
| 2029 | 8.54 | 17.33% |
| 2030 | 8.02 | 6.09% |
| 2031 | 7.94 | 1.00% |
| 2032 | 7.72 | 2.77% |
Based on analysts' sales estimates for 2025, the Porsche stock is valued at an EV/Sales of 0.51 and an P/S ratio of 0.54 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.39 | 53.01% |
|---|---|---|
| 2025 | 0.51 | 30.13% |
| 2026 | 0.49 | 2.52% |
| 2027 | 0.48 | 3.98% |
| 2028 | 0.44 | 8.29% |
| 2029 | 0.40 | 8.17% |
| 2030 | 0.39 | 3.65% |
| 2031 | 0.37 | 3.27% |
| 2032 | 0.36 | 4.51% |
P/S ratio
| Current | 0.42 | 47.50% |
|---|---|---|
| 2025 | 0.54 | 28.81% |
| 2026 | 0.53 | 2.52% |
| 2027 | 0.51 | 3.98% |
| 2028 | 0.47 | 8.31% |
| 2029 | 0.43 | 8.14% |
| 2030 | 0.41 | 3.66% |
| 2031 | 0.40 | 3.27% |
| 2032 | 0.38 | 4.51% |
Current Porsche Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ROTHSCHILD & CO REDBURN |
Neutral
➜
Neutral
|
Unchanged | Jul 14 2025 |
| METZLER EQUITIES |
Hold
➜
Sell
|
Downgrade | Jul 10 2025 |
| JEFFERIES |
Hold
➜
Hold
|
Unchanged | Jul 08 2025 |
| BERENBERG |
Hold
➜
Hold
|
Unchanged | Jun 30 2025 |
| BANCO SANTANDER |
Neutral
➜
Neutral
|
Unchanged | May 26 2025 |
| HSBC |
Hold
➜
Hold
|
Unchanged | May 25 2025 |
| LANDESBANK BADEN-WUERTTEMBERG |
Buy
➜
Buy
|
Unchanged | Apr 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
ROTHSCHILD & CO REDBURN:
Neutral
➜
Neutral
|
Jul 14 2025 |
|
Downgrade
METZLER EQUITIES:
Hold
➜
Sell
|
Jul 10 2025 |
|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Jul 08 2025 |
|
Unchanged
BERENBERG:
Hold
➜
Hold
|
Jun 30 2025 |
|
Unchanged
BANCO SANTANDER:
Neutral
➜
Neutral
|
May 26 2025 |
|
Unchanged
HSBC:
Hold
➜
Hold
|
May 25 2025 |
|
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Buy
➜
Buy
|
Apr 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
